Syra Health FY23 EPS $(0.60) Vs $(0.70) YoY; Revenue $5.5M Vs $5.6M YoY
Portfolio Pulse from Benzinga Newsdesk
Syra Health reported its FY23 earnings with an EPS of $(0.60) compared to $(0.70) the previous year. Revenue slightly decreased to $5.5M from $5.6M YoY. Notably, business units excluding Healthcare Workforce grew by 250%, and Population Health and Digital Health saw significant revenue increases. Gross profit margin improved to 25.6% from 18.9%, and the company ended the year with $3.3M in cash and no long-term debt.
March 25, 2024 | 12:47 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Syra Health's FY23 report shows a slight EPS improvement and a minor revenue decrease, with significant growth in specific business units and an improved gross profit margin.
The improvement in EPS and gross profit margin, along with the growth in key business units like Population Health and Digital Health, indicate a positive outlook for Syra Health. The lack of long-term debt and a healthy cash position further support a potentially positive short-term impact on SYRA's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90